The degree of systemic inflammation, as reflected by biomarkers such as CRP and ESR, has been independently associated with CV mortality, with baseline CRP or ESR within the first year of RA onset being predictive of future CV death [53]. The gene discussed is CRP; the disease is rheumatoid arthritis.